0001768309-22-000003.txt : 20220707 0001768309-22-000003.hdr.sgml : 20220707 20220707102514 ACCESSION NUMBER: 0001768309-22-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c FILED AS OF DATE: 20220707 DATE AS OF CHANGE: 20220707 EFFECTIVENESS DATE: 20220707 FILER: COMPANY DATA: COMPANY CONFORMED NAME: VedasLabs, Inc. CENTRAL INDEX KEY: 0001768309 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-451376 FILM NUMBER: 221070853 BUSINESS ADDRESS: STREET 1: 40 W. 89TH STREET STREET 2: UNIT 4B CITY: NEW YORK STATE: NY ZIP: 10024 BUSINESS PHONE: 917-588-3622 MAIL ADDRESS: STREET 1: 40 W. 89TH STREET STREET 2: UNIT 4B CITY: NEW YORK STATE: NY ZIP: 10024 D 1 primary_doc.xml X0708 D LIVE 0001768309 VedasLabs, Inc. 40 West 89th Street 4B New York NY NEW YORK 10024 (917) 588-3622 DELAWARE NYcommerce LLC None Corporation true 2018 Angelo Framularo 40 West 89th Street 4B New York NY NEW YORK 10024 Executive Officer Chief Compliance Officer Other Banking and Financial Services $1 - $1,000,000 06c false true false true false 5000 Umergence LLC 284368 Umergence LLC 284368 1006 S. Main Street Plantsville CT CONNECTICUT 06479 All States true 2000000 0 2000000 false 0 0 true 100000 true Umergence will be compensated a cash placement fee equal to (5%) of the gross proceeds. Upon the final closing of the Equity Financing the Company shall issue to UMG a stock purchase warrant equal (5%) of the aggregate investment received. 0 true false VedasLabs, Inc. Thomas Trevisani Thomas Trevisani CEO 2022-07-07